Company profile: Myst Therapeutics
1.1 - Company Overview
Company description
- Provider of novel broad-spectrum cancer immunotherapy products and adoptive cell therapies for solid tumors, harnessing a patient's own immune system via enriched tumor-derived T cells.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Myst Therapeutics
Q Therapeutics
HQ: United States
Website
- Description: Provider of cell-based therapeutics targeting central nervous system diseases, including amyotrophic lateral sclerosis; its Q-Cells human glial progenitor cells differentiate into astrocytes and oligodendrocytes to support neuron function and health.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Q Therapeutics company profile →
CellTran
HQ: United Kingdom
Website
- Description: Provider of biotechnology-based cell therapy and wound management products, focused on research and development for tissue regeneration and wound healing. Offers Myskin for difficult-to-heal wounds, Lyphoderm, a hydrophilic gel from freeze-dried lysate of cultured human keratinocytes, and Ulcodress.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CellTran company profile →
Ossium Health
HQ: United States
Website
- Description: Provider of a bank of cryopreserved bone marrow from deceased donors for cell therapies targeting hematologic diseases, including blood cancers, organ transplant rejection, and musculoskeletal defects; offering OssiGraft, a cryopreserved viable bone matrix allograft. Offers GMP human mesenchymal stem cells and selected CD34+ cells from vertebral bodies, plus research-use MSCs and CD34+ cells.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ossium Health company profile →
Organogenesis
HQ: United States
Website
- Description: Provider of regenerative medicine products, including PuraPly MZ, a micronized wound matrix made from purified porcine collagen to support healing in complex surgical wounds by inhibiting excess MMPs, and PuraForce, a purified collagen matrix used for tendon reinforcement during tendon repair surgeries, providing biomechanical strength and support without bulk.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Organogenesis company profile →
ImmunityBio
HQ: United States
Website
- Description: Provider of clinical-stage immunotherapy solutions focused on harnessing the immune system to treat disease.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ImmunityBio company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Myst Therapeutics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Myst Therapeutics
2.2 - Growth funds investing in similar companies to Myst Therapeutics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Myst Therapeutics
4.2 - Public trading comparable groups for Myst Therapeutics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →